OTC Statin Survey To Be Presented By NCL At January NDAC Meeting
This article was originally published in The Tan Sheet
Executive Summary
Survey data on probable OTC statin use and understanding will be presented during an upcoming FDA advisory committee meeting on the potential switch of a 20 mg dose of Merck's Mevacor (lovastatin)